ABTI - ALTEROLA BIOTECH INC.

0.0051
0.000   1.961%

Share volume: 10,000
Last Updated: 02-23-2026
Pharmaceutical Products/Medicinal Chemicals: 0.85%

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
82%
Profitability 100%
Dept financing 50%
Liquidity 26%
Performance 85%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
2,450.00%
1 Year
2,450.00%
2 Year
54.55%
Key data
Stock price
$0.01
P/E Ratio 
0.00
DAY RANGE
$0.01 - $0.01
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.20
52 WEEK CHANGE
$2,450.00
MARKET CAP 
5.838 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Timothy Paul Rogers
Region: US
Website: alterola-abti.com
Employees: 0
IPO year: 2019
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Alterola Biotech, Inc. engages in the development of cannabinoid and cannabinoid-like molecules. The company is based in Birkenhead, the United Kingdom.

Recent news